Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2006 Nov;80(22):11019-30.
doi: 10.1128/JVI.01382-06. Epub 2006 Sep 6.

Fusion-induced apoptosis contributes to thymocyte depletion by a pathogenic human immunodeficiency virus type 1 envelope in the human thymus

Affiliations

Fusion-induced apoptosis contributes to thymocyte depletion by a pathogenic human immunodeficiency virus type 1 envelope in the human thymus

Eric G Meissner et al. J Virol. 2006 Nov.

Abstract

The mechanisms of CD4(+) T-cell depletion during human immunodeficiency virus type 1 (HIV-1) infection remain incompletely characterized. Of particular importance is how CD4(+) T cells are depleted within the lymphoid organs, including the lymph nodes and thymus. Herein we characterize the pathogenic mechanisms of an envelope from a rapid progressor (R3A Env) in the NL4-3 backbone (NL4-R3A) which is able to efficiently replicate and deplete CD4(+) thymocytes in the human fetal-thymus organ culture (HF-TOC). We demonstrate that uninterrupted replication is required for continual thymocyte depletion. During depletion, NL4-R3A induces an increase in thymocytes which uptake 7AAD, a marker of cell death, and which express active caspase-3, a marker of apoptosis. While 7AAD uptake is observed predominantly in uninfected thymocytes (p24(-)), active caspase-3 is expressed in both infected (p24(+)) and uninfected thymocytes (p24(-)). When added to HF-TOC with ongoing infection, the protease inhibitor saquinavir efficiently suppresses NL4-R3A replication. In contrast, the fusion inhibitors T20 and C34 allow for sustained HIV-1 production. Interestingly, T20 and C34 effectively prevent thymocyte depletion in spite of this sustained replication. Apoptosis of both p24(-) and p24(+) thymocytes appears to be envelope fusion dependent, as T20, but not saquinavir, is capable of reducing thymocyte apoptosis. Together, our data support a model whereby pathogenic envelope-dependent fusion contributes to thymocyte depletion in HIV-1-infected thymus, correlated with induction of apoptosis in both p24(+) and p24(-) thymocytes.

PubMed Disclaimer

Figures

FIG. 1.
FIG. 1.
CD4+ thymocyte depletion is dependent on sustained viral replication. (A and B) Thymocytes from mock-, NL4-R3A-, and NL4-R3B-infected HF-TOC were analyzed using flow cytometry for forward and side scatter (% gated live) (A) and expression of CD4 on cells which were gated live (B). Shown are data from at least seven independent experiments. (*, P < 0.05 for the NL4-R3A trend line relative to mock and NL4-R3B.) (C and D) Saquinavir was added to NL4-R3A-infected HF-TOC 6 (C) or 8 (D) days postinfection and each day thereafter, with the first day of drug addition indicated by the arrow. CD4+ thymocyte depletion was assessed at the indicated times. Error bars are from quadruplicate samples (*, P < 0.05 by the student's t test for NL4-R3A with drug relative to NL4-R3A without drug).
FIG. 2.
FIG. 2.
Increase in 7AAD+ thymocytes in NL4-R3A-infected HF-TOC is predominantly in the p24 population. (A) Cells in the scatter-defined live cell gate were stained for 7AAD to measure dead cells and p24 to measure productively infected cells. Shown are representative plots for mock-, NL4-R3A-, and NL4-R3B-infected thymus at 9 and 12 dpi. (B) The percentage of 7AAD+ thymocytes in the live gate for mock-, NL4-R3A-, and NL4-R3B-infected thymus over time. (*, P < 0.05 for NL4-R3A trend line relative to mock and NL4-R3B.) (C) The increase in 7AAD+ cells occurs predominantly in the uninfected (p24) population of the NL4-R3A-infected thymus. The proportion of uninfected thymocytes (p24 thymocytes) and infected thymocytes (p24+ thymocytes) which are 7AAD+ is shown. (B and C) Data are from seven independent experiments. (*, P < 0.05 for p24 trend line relative to p24+.)
FIG. 3.
FIG. 3.
Infection with NL4-R3A increases the frequency of thymocytes expressing active caspase-3. (A) 7AAD-negative live cells were stained for p24 and active caspase-3. Shown is a representative of seven independent experiments from 9 and 12 dpi for mock-, NL4-R3A-, and NL4-R3B-infected thymus. (B) NL4-R3A increases the frequency of total thymocytes with active caspase-3 expression (*, P < 0.05 for NL4-R3A trend line relative to mock and NL4-R3B.) (C) The increase in active caspase-3+ cells in NL4-R3A-infected HF-TOC occurs in both uninfected (p24) and infected (p24+) thymocytes in proportion to the level of NL4-R3A replication. (*, P < 0.05 for the strength of significance for each trend line.) (B and C) Data are from seven independent experiments.
FIG. 4.
FIG. 4.
Most caspase-3+ thymocytes in NL4-R3A-infected HF-TOC do not express p24. Fragments from mock- and NL4-R3A-infected thymus at 12 dpi were stained for p24 (green; Fluor 546) and active caspase-3 (red; Fluor 488). Shown is a representative of two independent experiments. Low (×20) and high (×60) magnifications are shown. Isotype control antibodies showed no specific signals (data not shown).
FIG. 5.
FIG. 5.
Prevention of thymocyte depletion in T20- and C34-treated HF-TOC in spite of sustained replication. (A to C) NL4-R3A-infected HF-TOC was treated with C34, T20, or saquinavir from 7 dpi for 6 days. Arrows indicate the day of drug addition. (A) Viral load was quantitated by ELISA detection of Gag antigen in the HF-TOC supernatant on the indicated days. Error bars are derived from triplicate samples. (*, P < 0.05 by the student's t test for drug treatment relative to no drug.) (B and C) Similar percentages of CD4+ thymocyte protection after T20, C34, and saquinavir treatment were detected 6 days after drug treatment by CD4 and CD8 staining. Error bars are derived from triplicate samples. Shown is a representative of three independent experiments. (*, P < 0.05 by the student's t test relative to no drug.)
FIG. 6.
FIG. 6.
Apoptosis in NL4-R3A-infected HF-TOC is inhibited by T20. (A) NL4-R3A-infected HF-TOC was treated with saquinavir or T20 at 6 dpi for up to 4 days. Thymocytes were stained with 7AAD, p24, and active caspase-3. Shown is a representative of five experiments for 7AAD live cells 3 days after drug addition. (B) The frequency of bystander apoptosis (percent caspase-3+ p24) was determined for each experimental treatment. The combined data for all time points from five independent experiments are shown with standard error bars. (mean percentage p24+ of 14% for no drug, 4.5% for saquinavir, and 5.7% for T20). (C) Saquinavir increased, but T20 decreased, apoptosis of infected thymocytes. To compare HF-TOC with similar levels of replication, only samples with less than 7% p24+ were considered for “no drug” treatment (mean percent p24+ of 4.4% for no drug, 4.5% for saquinavir, and 5.7% for T20). (*, P < 0.05 by the student's t test relative to no drug for panels B and C.)

Similar articles

Cited by

References

    1. Ahr, B., V. Robert-Hebmann, C. Devaux, and M. Biard-Piechaczyk. 2004. Apoptosis of uninfected cells induced by HIV envelope glycoproteins. Retrovirology 1:12. - PMC - PubMed
    1. Alimonti, J. B., T. B. Ball, and K. R. Fowke. 2003. Mechanisms of CD4+ T lymphocyte cell death in human immunodeficiency virus infection and AIDS. J. Gen. Virol. 84:1649-1661. - PubMed
    1. Bar, S., and M. Alizon. 2004. Role of the ectodomain of the gp41 transmembrane envelope protein of human immunodeficiency virus type 1 in late steps of the membrane fusion process. J. Virol. 78:811-820. - PMC - PubMed
    1. Biard-Piechaczyk, M., V. Robert-Hebmann, V. Richard, J. Roland, R. A. Hipskind, and C. Devaux. 2000. Caspase-dependent apoptosis of cells expressing the chemokine receptor CXCR4 is induced by cell membrane-associated human immunodeficiency virus type 1 envelope glycoprotein (gp120). Virology 268:329-344. - PubMed
    1. Bonyhadi, M. L., L. Rabin, S. Salimi, D. A. Brown, J. Kosek, J. M. McCune, and H. Kaneshima. 1993. HIV induces thymus depletion in vivo. Nature 363:728-732. - PubMed

Publication types

MeSH terms